Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Mrinal Joel"'
Autor:
Wayne Murrell, Emily Palmero, John Bianco, Biljana Stangeland, Mrinal Joel, Linda Paulson, Bernd Thiede, Zanina Grieg, Ingunn Ramsnes, Håvard K Skjellegrind, Ståle Nygård, Petter Brandal, Cecilie Sandberg, Einar Vik-Mo, Sheryl Palmero, Iver A Langmoen
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e71334 (2013)
The discovery of stem cells in the adult human brain has revealed new possible scenarios for treatment of the sick or injured brain. Both clinical use of and preclinical research on human adult neural stem cells have, however, been seriously hampered
Externí odkaz:
https://doaj.org/article/e447bd1252084b438336d0ade57ddc79
Autor:
Jean-Luc Boulland, Doreen S. Y. Leung, Marte Thuen, Einar Vik-Mo, Mrinal Joel, Marie-Claude Perreault, Iver A. Langmoen, Olav Haraldseth, Joel C. Glover
Publikováno v:
Cell Transplantation, Vol 21 (2012)
Magnetic resonance imaging (MRI)-based tracking is increasingly attracting attention as a means of better understanding stem cell dynamics in vivo. Intracellular labeling with micrometer-sized particles of iron oxide (MPIOs) provides a practical MRI-
Externí odkaz:
https://doaj.org/article/53ebf9cf789844d9851a0c6eaf1cff29
Autor:
Randi G. Syljuåsen, Grete Hasvold, Mrinal Joel, Gro Elise Rødland, Sissel Hauge, Tine T. H. Raabe, Lilli T. E. Bay
Publikováno v:
Cancers
Cancers, Vol 13, Iss 3790, p 3790 (2021)
Volume 13
Issue 15
Cancers, Vol 13, Iss 3790, p 3790 (2021)
Volume 13
Issue 15
Simple Summary Cancer cells often show elevated replication stress and loss of cell cycle checkpoints. The ataxia telangiectasia and Rad3-related (ATR) and WEE1 kinases play roles in protecting cancer cells from high replication stress and in regulat
Autor:
Randi G. Syljuåsen, Mrinal Joel, Grete Hasvold, Petras Juzenas, Sissel Hauge, Christian Naucke, Trond Stokke, Gro Elise Rødland
Publikováno v:
Oncotarget
// Sissel Hauge 1 , Christian Naucke 1 , Grete Hasvold 1 , Mrinal Joel 1 , Gro Elise Rodland 1 , Petras Juzenas 1 , Trond Stokke 1 , Randi G. Syljuasen 1 1 Department of Radiation Biology, Institute for Cancer Research, Norwegian Radium Hospital, Osl
Autor:
P Isakson, Sam Hosainey, Jan E. Brinchmann, TK Olsen, Biljana Stangeland, Mrinal Joel, Joel C. Glover, Francesca Micci, J Behnan
Publikováno v:
Oncogene
Glioblastoma Multiforme (GBM) is characterized by high cancer cell heterogeneity and the presence of a complex tumor microenvironment. Those factors are a key obstacle for the treatment of this tumor type. To model the disease in mice, the current st
Autor:
Wiaam Badn, Mrinal Joel, J Behnan, Einar O. Vik-Mo, Corrado M. Cilio, Pauline Isakson, Iver A. Langmoen
Publikováno v:
STEM CELLS. 32:1110-1123
The identity of the cells that contribute to brain tumor structure and progression remains unclear. Mesenchymal stem cells (MSCs) have recently been isolated from normal mouse brain. Here, we report the infiltration of MSC-like cells into the GL261 m
Autor:
Einar O. Vik-Mo, Cecilie Sandberg, Mrinal Joel, Jean-Luc Boulland, Joel C. Glover, Iver A. Langmoen
Publikováno v:
Developmental Dynamics. 242:1078-1093
Background: Tissue microenvironment plays key roles in regulating the progression of aggressive tumors. Tumors are uncommon in the early embryo, suggesting that embryonic tissue microenvironments are nonpermissive for tumors. Yet, the effects of embr
Autor:
Marte Thuen, Iver A. Langmoen, Mrinal Joel, Olav Haraldseth, Joel C. Glover, Einar O. Vik-Mo, Marie-Claude Perreault, Doreen Siu Yi Leung, Jean-Luc Boulland
Publikováno v:
Cell Transplantation, Vol 21 (2012)
Magnetic resonance imaging (MRI)-based tracking is increasingly attracting attention as a means of better understanding stem cell dynamics in vivo. Intracellular labeling with micrometer-sized particles of iron oxide (MPIOs) provides a practical MRI-
Autor:
Biljana Stangeland, Ståle Nygård, Iver A. Langmoen, Awais A. Mughal, Torstein R. Meling, Mrinal Joel, Wayne Murrell, Cecilie Sandberg, Zanina Grieg, Einar O. Vik Mo
Publikováno v:
Oncotarget, Vol. 6, No 28 (2015) pp. 26192-215
Oncotarget
Oncotarget
Glioblastoma (GBM) is both the most common and the most lethal primary brain tumor. It is thought that GBM stem cells (GSCs) are critically important in resistance to therapy. Therefore, there is a strong rationale to target these cells in order to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78a446a2209a58ccace75474e2efb5a9
https://archive-ouverte.unige.ch/unige:111892
https://archive-ouverte.unige.ch/unige:111892
Autor:
Awais A, Mughal, Zanina, Grieg, Håvard, Skjellegrind, Artem, Fayzullin, Mustapha, Lamkhannat, Mrinal, Joel, M Shakil, Ahmed, Wayne, Murrell, Einar O, Vik-Mo, Iver A, Langmoen, Biljana, Stangeland
Publikováno v:
Molecular Cancer
Background Glioblastoma (GBM) is the most common primary brain malignancy and confers a dismal prognosis. GBMs harbor glioblastoma-initiating cells (GICs) that drive tumorigenesis and contribute to therapeutic resistance and tumor recurrence. Consequ